Publichnoe Aktsionernoe Obschestvo Promomed Sustainability Reports
Public Joint Stock Company Promomed develops, manufactures, and sells a wide variety of medical and pharmaceutical products. Its portfolio focuses heavily on endocrinology, targeted oncology, antivirals, antibiotics, and treatments for autoimmune diseases.
Sector: Manufacturing
Country: Russia
Exchange: Moscow Exchange
FIGI: BBG01NSCZHL2
2 reports from 2025 to 2025
